COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Telemedicine for Patients Suffering From Heart Failure (Danish Telecare North Trial) (TCN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02860013
Recruitment Status : Unknown
Verified August 2016 by Ole K. Hejlesen, Aalborg University.
Recruitment status was:  Not yet recruiting
First Posted : August 9, 2016
Last Update Posted : August 9, 2016
Information provided by (Responsible Party):
Ole K. Hejlesen, Aalborg University

Brief Summary:

There are two main aims in this study. The first objective is to evaluate whether a particular telehealth solution, in addition to standard treatment and care, lead to a significant decrease in the mortality and an increase in health related quality of life for patients suffering from Heart Failure that may benefit from telehealth compared with only standard treatment and care. The second objective is to examine the additional costs of the telehealth solution and assess whether this solution is a cost-effective way to care for patients with Heart Failure across patients and municipality districts.

It is hypothesized that telehealth care will increase patients quality adjusted life years compared to usual practice, since no difference in mortality and a higher health related quality of life is expected. Furthermore, it is hoped that there will be a 30% reduction in the number of admissions and readmissions to hospitals and a 30% reduction in the number of outpatient visits resulting in fewer costs for hospitals. However, it is uncertain as to whether these savings are offset by other costs such as more visits to general practitioners, community care or the implementation costs.

Condition or disease Intervention/treatment Phase
Heart Failure Device: Telemedicine Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 600 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effectiveness and Cost-effectiveness of Telemedicine for Heart Failure: The Danish "TeleCare North" Pragmatic Randomized Trial
Study Start Date : August 2016
Estimated Primary Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
Active Comparator: Telemedicine
A tablet (a Samsung GALAXY TAB 2 (10.1)) that holds information on handling heart failure in general. The device can also collect and transmit relevant disease-specific data, which are indicative of their current state of health, via a Digital Blood Pressure Monitor (Model UA-767, plus BT-C) and a scale. The device can measure four vital signs, which are transferred wirelessly: blood pressure, pulse, and weight. The tablet can be activated and give a sound, when it is time for taking measurements again.
Device: Telemedicine
No Intervention: Usual care
In Denmark, usual practice for treating, monitoring and caring for patients with heart failure are the responsibility of the patient's general practitioner (treatment and monitoring) and the municipalities (practical help and nursing care). Heart failure patients can make appointments with their general practitioner or practice nurse free of charge in order to get help in managing heart failure. Community based care and practical help varies. As a rule community care comes at regular intervals based on a clinically based estimate of the patients' needs, but the personnel are not necessarily certified nurses and often not fully educated in heart failure and definitely not on call

Primary Outcome Measures :
  1. Mental health related quality of life (SF-36 questionnaire mental scores) [ Time Frame: 12 month follow-up ]
    Changes in mental health-related quality of life (SF-36 questionnaire mental score) at baseline to follow-up.

  2. Incremental cost-effectiveness ratio (ICER) [ Time Frame: 12 month follow-up ]
    The main outcome for cost is incremental cost-effectiveness ratio (ICER). ICER is measured as the total cost per quality adjusted life years (QALY) increased from baseline to follow-up.

Secondary Outcome Measures :
  1. Changes in daily functioning (KCCQ questionnaire score) [ Time Frame: 12 month follow-up ]
    Changes in daily functioning measured by KCCQ questionnaire score.

  2. Physical health related quality of life (SF-36 questionnaire Physical scores) [ Time Frame: 12 month follow-up ]
    Changes in physical health-related quality of life (SF-36 questionnaire physical score) at baseline to follow-up.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All heart failure patients that may benefit from telehealthcare.
  • Participants are qualified for inclusion if they have been diagnosed with HF according to national guidelines and are NYHA classified 2,3, and 4.
  • Patients must have a permanent residence and be motivated for using telehealthcare. *Patients must have a landline or mobile phone and be able to speak Danish or they must live with a relative speaking Danish. Such that the relative must be able to help the patient in translating the information in the use of telehealthcare.

Exclusion Criteria:

  • Patients without landline phone / mobile phone or GSM (Global System for Mobile Communications) coverage.
  • Patients not able to understand Danish adequately to complete the questionnaires in the study or patients having a cognitive impairment.
  • Comorbidity is not an exclusion criterion.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02860013

Layout table for location contacts
Contact: Ole Hejlesen, Professor
Contact: Lars Ehlers, Professor

Sponsors and Collaborators
Aalborg University
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Ole K. Hejlesen, Professor, Aalborg University Identifier: NCT02860013    
Other Study ID Numbers: telecare nord heart failure
First Posted: August 9, 2016    Key Record Dates
Last Update Posted: August 9, 2016
Last Verified: August 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Ole K. Hejlesen, Aalborg University:
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases